Project Grant HT94252410562
Award Date
6/1/24
Completion Date
5/31/27
Dollars Obligated
$655K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Providence, RI 02903, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency awarded a $1,107,000 Project Grant to Rhode Island Hospital, a division of Lifespan Corp, to support the "ENGINEERED NEUTROPHILS FOR INTRATUMORAL DELIVERY AND TARGETING" research project. This grant, funded through the Military Medical Research and Development (CFDA 12.420) program, will be used to conduct basic, translational, and clinical research aimed at developing new treatments and improving patient care related to cancer,...
The federal Project Grant award of $856,523.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research to transform healthcare for military service members and the public. The award, effective September 30, 2025 through September 29, 2028, will fund research by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to investigate neurovascular and cognitive recovery from a...
The federal Project Grant award of $718,829.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports research conducted by Brigham & Women's Hospital Inc. (a subsidiary of Partners Healthcare System Incorporated) to investigate the use of the compounds ergothioneine and ovothiol A as potential treatments for traumatic brain injury and comorbid alcohol use disorder. The research aims to advance disease...
The Defense Health Agency awarded Brigham & Women's Hospital Inc. a $253,636 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2025 to investigate the role of the secreted factor CTHRC1 in the pathogenesis of tuberous sclerosis complex. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
This federal Project Grant award of $2,377,839.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports evidence-based prediction of cardiovascular risk in immune-mediated inflammatory disease. The award, granted to the Regents of the University of California, San Francisco on June 1, 2025, aims to advance biomedical research and transform healthcare for military service members and the broader public. The 4-year research...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research to understand factors and disclosure responses that predict psychological distress in male and female survivors of military sexual assault. The total award amount is $1,275,092 over the period of Aug 15, 2024 to Aug 14, 2028. Arizona State University is the prime awardee, with a sub-award to the University of California, Irvine to support...
The federal Project Grant award, funded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), provides $183,258 to the East Bay Institute for Research & Education Inc. to conduct longitudinal monitoring of cognitive changes in older veterans using telehealth computerized neuropsychological assessments. This 3-year research project, which commenced on March 1, 2025, aims to advance medical understanding and treatment...
This federal Project Grant award of $6,381,198 from the Defense Health Agency was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) on August 1, 2024. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports a range of biomedical research initiatives to improve health outcomes for military personnel, veterans, and the public. The "GET BETTER TOGETHER: A PRIMARY PREVENTION INTERVENTION FOR MILITARY...
This federal Project Grant award of $1,991,326.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) aimed at suppressing barrier antimicrobial defenses in the context of trauma. The 3-year grant, with a performance period from September 30, 2024 to September 29, 2027, will enable Bidmc, a prominent academic medical center in...
This Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) provides $168,042.00 to Brigham & Women's Hospital Inc. (a subsidiary of Partners Healthcare System Incorporated) to conduct in-vivo research targeting TFE3 dimerization partners in translocation renal cell carcinoma. The award commenced on August 1, 2025 and is scheduled for completion by July 31, 2026. The Military Medical Research and Development...